Vemurafenib in BRAF-mutant metastatic melanoma patients in real-world clinical practice: prognostic factors associated with clinical outcomes

MG Schouwenburg; A Jochems; Brenda Leeneman; Margreet Franken; AJM Van den Eertwegh; J Haanen; MCT van Zeijl; MJ Aarts; ACJ Akkooi; F van den Berkmortel; WAM Blokx; JWB de Groot; GAP Hospers; E Kapiteijn; RH Koornstra; Wim Kruit; MWJ Louwman; D Piersma; RS van Rijn; KPM Suijkerbuijk; AJ ten Tije; G Vreugdenhil; M Wouters; JJM van der Hoeven

doi:10.1097/cmr.0000000000000453

Vemurafenib in BRAF-mutant metastatic melanoma patients in real-world clinical practice: prognostic factors associated with clinical outcomes

MG Schouwenburg
, A Jochems
, Brenda Leeneman
, Margreet Franken
, AJM Van den Eertwegh
, J Haanen
, MCT van Zeijl
, MJ Aarts
, ACJ Akkooi
, F van den Berkmortel
, WAM Blokx
, JWB de Groot
, GAP Hospers
, E Kapiteijn
, RH Koornstra
, Wim Kruit
, MWJ Louwman
, D Piersma
, RS van Rijn
, KPM Suijkerbuijk

AJ ten Tije, G Vreugdenhil, M Wouters, JJM van der Hoeven

Research output: Contribution to journal › Article › Academic › peer-review

9 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	326-332
Number of pages	7
Journal	Melanoma Research
Volume	28
Issue number	4
DOIs	https://doi.org/10.1097/cmr.0000000000000453
Publication status	Published - 2018

Research programs

EMC NIHES-05-63-02 Quality
EMC MM-03-86-08

Access to Document

10.1097/cmr.0000000000000453

http://hdl.handle.net/1765/109277

Cite this

Schouwenburg, MG., Jochems, A., Leeneman, B., Franken, M., Van den Eertwegh, AJM., Haanen, J., van Zeijl, MCT., Aarts, MJ., Akkooi, ACJ., van den Berkmortel, F., Blokx, WAM., de Groot, JWB., Hospers, GAP., Kapiteijn, E., Koornstra, RH., Kruit, W., Louwman, MWJ., Piersma, D., van Rijn, RS., ... van der Hoeven, JJM. (2018). Vemurafenib in BRAF-mutant metastatic melanoma patients in real-world clinical practice: prognostic factors associated with clinical outcomes. Melanoma Research, 28(4), 326-332. https://doi.org/10.1097/cmr.0000000000000453

@article{a7f6e8b7411e4a49a1108aceefce2747,

title = "Vemurafenib in BRAF-mutant metastatic melanoma patients in real-world clinical practice: prognostic factors associated with clinical outcomes",

author = "MG Schouwenburg and A Jochems and Brenda Leeneman and Margreet Franken and \{Van den Eertwegh\}, AJM and J Haanen and \{van Zeijl\}, MCT and MJ Aarts and ACJ Akkooi and \{van den Berkmortel\}, F and WAM Blokx and \{de Groot\}, JWB and GAP Hospers and E Kapiteijn and RH Koornstra and Wim Kruit and MWJ Louwman and D Piersma and \{van Rijn\}, RS and KPM Suijkerbuijk and \{ten Tije\}, AJ and G Vreugdenhil and M Wouters and \{van der Hoeven\}, JJM",

year = "2018",

doi = "10.1097/cmr.0000000000000453",

language = "Undefined/Unknown",

volume = "28",

pages = "326--332",

journal = "Melanoma Research",

issn = "0960-8931",

publisher = "Lippincott Williams \& Wilkins",

number = "4",

}

Schouwenburg, MG, Jochems, A, Leeneman, B, Franken, M, Van den Eertwegh, AJM, Haanen, J, van Zeijl, MCT, Aarts, MJ, Akkooi, ACJ, van den Berkmortel, F, Blokx, WAM, de Groot, JWB, Hospers, GAP, Kapiteijn, E, Koornstra, RH, Kruit, W, Louwman, MWJ, Piersma, D, van Rijn, RS, Suijkerbuijk, KPM, ten Tije, AJ, Vreugdenhil, G, Wouters, M & van der Hoeven, JJM 2018, 'Vemurafenib in BRAF-mutant metastatic melanoma patients in real-world clinical practice: prognostic factors associated with clinical outcomes', Melanoma Research, vol. 28, no. 4, pp. 326-332. https://doi.org/10.1097/cmr.0000000000000453

TY - JOUR

T1 - Vemurafenib in BRAF-mutant metastatic melanoma patients in real-world clinical practice: prognostic factors associated with clinical outcomes

AU - Schouwenburg, MG

AU - Jochems, A

AU - Leeneman, Brenda

AU - Franken, Margreet

AU - Van den Eertwegh, AJM

AU - Haanen, J

AU - van Zeijl, MCT

AU - Aarts, MJ

AU - Akkooi, ACJ

AU - van den Berkmortel, F

AU - Blokx, WAM

AU - de Groot, JWB

AU - Hospers, GAP

AU - Kapiteijn, E

AU - Koornstra, RH

AU - Kruit, Wim

AU - Louwman, MWJ

AU - Piersma, D

AU - van Rijn, RS

AU - Suijkerbuijk, KPM

AU - ten Tije, AJ

AU - Vreugdenhil, G

AU - Wouters, M

AU - van der Hoeven, JJM

PY - 2018

Y1 - 2018

U2 - 10.1097/cmr.0000000000000453

DO - 10.1097/cmr.0000000000000453

M3 - Article

SN - 0960-8931

VL - 28

SP - 326

EP - 332

JO - Melanoma Research

JF - Melanoma Research

IS - 4

ER -